SELLAS Life Sciences Group, Inc. License Agreements

37 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Ex-10.11 Exclusive license Agreement between CytRx Corporation and the University of Massachusetts Medical School ((03-17)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
License Agreement effective as of March 31, 2022 by and between SELLAS Life Sciences Group, Inc. and GenFleet Therapeutics (Shanghai) Inc
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2022
Exclusive License Agreement by and among SELLAS, SLSG, and 3DMed, dated as of December 7, 2020
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2021
First Amendment to Amended and Restated Exclusive License Agreement between SLSG Limited LLC and Memorial Sloan Kettering Cancer Center, effective as of September 29, 2020
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2020
License Agreement made as of May 19, 2018 by and between the Registrant and 38th Street Suites LLC
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2018
Amendment of the Exclusive License Agreement by and between Mills Pharmaceuticals, LLC and BioVascular, Inc
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2017
LICENSE AND SUPPLY TRANSFER AGREEMENT
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2016
LICENSE AND SUPPLY AGREEMENT By and between MONOSOL RX, LLC, and
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
DE
2014
EXCLUSIVE LICENSE AGREEMENT
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
NY
2014
LICENSE AND DEVELOPMENT AGREEMENT
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
DE
2014
LICENSE AGREEMENT
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
CA
2013
AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
2012
LICENSE AGREEMENT
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
AZ
2012
Ex-10.30 Patent License Agreement (Invitrogen IP Holdings, Inc.) dated November 1, 2007
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.14 License Agreemnet, dated May 19,2004
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.13 Co-Exclusive License Agreement, to UMMS disclosure number 03-33
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.12 Exclusive License Agreement, to UMMS disclosure number 03-60
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.11 Exclusive License Agreement, to UMMS disclosure number 03-17
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.10 Amended and Restated Exclusive License Agreement
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.9 Exclusive License Agreement, to UMMS disclosure number 02-01
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.8 Non-Exclusive License Agreement, to UMMS disclosure number 01-36
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.7 Exclusive License Agreement (No.: UMMC 06-08-03)
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.6 Exclusive License Agreement (No.: UMMC 03-75-01)
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.5 Exclusive License Agreement (No.: UMMC 03-68-02)
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.4 Exclusive License Agreement (No.: UMMC 06-21-01)
License Agreements
SELLAS Life Sciences Group, Inc.
2008
EX-10.2 License Agreement, dated March 15, 2007
License Agreements
SELLAS Life Sciences Group, Inc.
2008
Ex-10.14 License Agreement between CytRx Corporation, Imperial College Innovations and Imperial College of Science and Technology, dated May 20, 2004
License Agreements
SELLAS Life Sciences Group, Inc.
2007
Ex-10.13 Exclusive License Agreement between CytRx Corporation and the University of Massachusetts Medical School (03-33)
License Agreements
SELLAS Life Sciences Group, Inc.
2007
Ex-10.12 Exclusive License Agreement between CytRx Corporation and the University of Massachusetts Medical School (03-60)
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
Ex-10.10 Amended and Restated Exclusive License Agreement between CytRx Corporation and the University of Massachusetts Medical School (03-05, 00-37, 01-31, 03-134, 93-09 and...
License Agreements
SELLAS Life Sciences Group, Inc.
2007
Ex-10.9 Exclusive License Agreement between CytRx Corporation and the University of Massachusetts Medical School (02-01)
License Agreements
SELLAS Life Sciences Group, Inc.
2007
Ex-10.8 Non-Exclusive License Agreement, between CytRx Corporation and the University of Massachusetts Medical School (01-36)
License Agreements
SELLAS Life Sciences Group, Inc.
2007
Ex-10.7 Non-Exclusive License Agreement (No.: UMMC 06-08-03) between the University of Massachusetts and RXi Pharmaceuticals Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
2007
Ex-10.6 Exclusive License Agreement (No.: UMMC 03-75-01) between the University of Massachusetts and RXi Pharmaceuticals Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
2007
Ex-10.5 Exclusive License Agreement (No.: UMMC 03-68-02) between the University of Massachusetts and RXi Pharmaceuticals Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
Biotechnology
MA
2007
Ex-10.4 Exclusive License Agreement (No.: UMMC 06-21-01) between the University of Massachusetts and RXi Pharmaceuticals Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
2007
Ex-10.2 License Agreement between Cold Spring Harbor Laboratory and RXi Pharmaceuticals Corporation
License Agreements
SELLAS Life Sciences Group, Inc.
2007